Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis
暂无分享,去创建一个
W. Hellstrom | M. Gelbard | L. Trost | M. Ziegelmann | R. Virasoro | Hoang Minh Tue Nguyen | L. Alzweri | A. Tapscott | A. Chung
[1] M. Falcone,et al. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol , 2017, BJU international.
[2] W. Hellstrom,et al. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease. , 2017, The journal of sexual medicine.
[3] N. Bennett,et al. Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms. , 2016, Urology.
[4] L. Trost,et al. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease. , 2016, The Journal of urology.
[5] G. Kaufman,et al. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD) , 2015, BJU international.
[6] I. Goldstein,et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. , 2013, The Journal of urology.
[7] C. Nelson,et al. Psychological impact of Peyronie's disease: a review. , 2013, The journal of sexual medicine.
[8] Xiaolei Zhou,et al. A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States , 2011, Advances in urology.
[9] T. Lue,et al. Risk factors for emotional and relationship problems in Peyronie's disease. , 2008, The journal of sexual medicine.
[10] C. Nelson,et al. The chronology of depression and distress in men with Peyronie's disease. , 2008, The journal of sexual medicine.
[11] Stephen A Boorjian,et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. , 2004, The Journal of urology.
[12] T. H. Klotz,et al. Epidemiology of Peyronie's disease , 2002, International Journal of Impotence Research.
[13] P. Grambsch,et al. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. , 1991, The Journal of urology.
[14] F. Dorey,et al. The natural history of Peyronie's disease. , 1990, The Journal of urology.